- Home
- ENIC vs ZLAB Comparison
ENIC vs ZLAB Comparison
Compare ENIC & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENIC
- ZLAB
- Stock Information
- Founded
- ENIC 2016
- ZLAB 2013
- Country
- ENIC Chile
- ZLAB China
- Employees
- ENIC N/A
- ZLAB N/A
- Industry
- ENIC Electric Utilities: Central
- ZLAB Biotechnology: Pharmaceutical Preparations
- Sector
- ENIC Utilities
- ZLAB Health Care
- Exchange
- ENIC Nasdaq
- ZLAB Nasdaq
- Market Cap
- ENIC 4.8B
- ZLAB 4.3B
- IPO Year
- ENIC N/A
- ZLAB 2017
- Fundamental
- Price
- ENIC $3.19
- ZLAB $36.82
- Analyst Decision
- ENIC Hold
- ZLAB Buy
- Analyst Count
- ENIC 2
- ZLAB 5
- Target Price
- ENIC $3.90
- ZLAB $54.28
- AVG Volume (30 Days)
- ENIC 693.6K
- ZLAB 839.9K
- Earning Date
- ENIC 07-29-2025
- ZLAB 08-07-2025
- Dividend Yield
- ENIC 5.89%
- ZLAB N/A
- EPS Growth
- ENIC N/A
- ZLAB N/A
- EPS
- ENIC 0.00
- ZLAB N/A
- Revenue
- ENIC $4,054,679,917.00
- ZLAB $418,326,000.00
- Revenue This Year
- ENIC $113,212.22
- ZLAB $44.07
- Revenue Next Year
- ENIC $0.32
- ZLAB $49.13
- P/E Ratio
- ENIC $33.40
- ZLAB N/A
- Revenue Growth
- ENIC N/A
- ZLAB 43.72
- 52 Week Low
- ENIC $2.51
- ZLAB $16.01
- 52 Week High
- ENIC $4.05
- ZLAB $44.34
- Technical
- Relative Strength Index (RSI)
- ENIC 32.12
- ZLAB 50.98
- Support Level
- ENIC $3.10
- ZLAB $36.51
- Resistance Level
- ENIC $3.33
- ZLAB $41.20
- Average True Range (ATR)
- ENIC 0.07
- ZLAB 1.21
- MACD
- ENIC -0.01
- ZLAB 0.18
- Stochastic Oscillator
- ENIC 24.29
- ZLAB 42.75
About ENIC Enel Chile S.A. (Each representing 50 shares of)
Enel Chile SA is an electricity utility company, which through its subsidiaries and affiliates is engaged in the generation, transmission and distribution of electricity businesses in Chile. It operates through two segments including Generation Business and Distribution and Network Business. The Generation Business Segment is comprised of a group of electricity companies that own electricity generating plants, whose energy is transmitted and distributed to end customers. The Distribution and Network Reportable Segment is comprised of a group of electricity companies operating under a public utility concession.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.